ABO血型不合的异基因造血干细胞移植后，大剂量地塞米松成功治疗纯红细胞再生障碍性贫血。
Successful treatment of pure red cell aplasia with high-dose dexamethasone after ABO-incompatible allogeneic hematopoietic stem cell transplantation.
作者信息
Varela Gómez Rosario, Vázquez Vázquez Goretti, Noriega Concepción Victor, Galego García Andrea, Andón Saavedra Concepción
机构信息
Departamento de Hematología, Hospital Universitario A Coruña, A Coruña, Spain.
Departamento de Hematología, Complejo Hospitalario Universitario de Ferrol, A Coruña, Spain.
出版信息
Hematol Oncol Stem Cell Ther. 2018 Mar;11(1):44-46. doi: 10.1016/j.hemonc.2017.08.004. Epub 2017 Oct 18.
The literature reports an incidence of Pure Red Cell Aplasia (PRCA) ranging from 6-30% of all cases of ABO-incompatible HSCT. Although most patients resolve spontaneously after withdrawal immunosuppression, some of them require more aggressive treatment to manage this condition.
文献报道，纯红细胞再生障碍性贫血（PRCA）的发生率在所有ABO血型不合的造血干细胞移植病例中占6%至30%。尽管大多数患者在停用免疫抑制剂后可自发缓解，但其中一些患者需要更积极的治疗来控制这种情况。
Zotero 插件